Stock Options, Common Stock and Warrants - Warrants by Exercise Price (Details) (USD $)
|
12 Months Ended | 1 Months Ended | 11 Months Ended | |
---|---|---|---|---|
Dec. 31, 2013
|
Dec. 31, 2014
|
Jan. 31, 2013
|
Dec. 31, 2013
|
|
Row 44 Warrants | ||||
Number of Warrants [Abstract] | ||||
Beginning Balance |
2,898,810us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber / us-gaap_PlanNameAxis = ent_Row44WarrantsMember |
2,898,810us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber / us-gaap_PlanNameAxis = ent_Row44WarrantsMember |
||
Weighted Average Exercise Price [Abstract] | ||||
Beginning Balance (in dollars per share) |
$ 2.34us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue / us-gaap_PlanNameAxis = ent_Row44WarrantsMember |
$ 2.34us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue / us-gaap_PlanNameAxis = ent_Row44WarrantsMember |
||
Outstanding, Weighted Average Remaining Contractual Term (in years) | 4 years 11 months 1 day | |||
Row 44 Warrants | Common stock warrants | ||||
Share-based Compensation, Shares Authorized under Equity Instruments Other Than Options, Exercise Price Range [Line Items] | ||||
Exercise Price Per Warrant (as converted) |
$ 8.79ent_SharebasedCompensationSharesAuthorizedunderEquityInstrumentsOtherThanOptionsExercisePricePerWarrantasConverted / us-gaap_ClassOfWarrantOrRightAxis = ent_CommonStockWarrantsMember / us-gaap_PlanNameAxis = ent_Row44WarrantsMember |
|||
Exercisable |
690,000ent_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber / us-gaap_ClassOfWarrantOrRightAxis = ent_CommonStockWarrantsMember / us-gaap_PlanNameAxis = ent_Row44WarrantsMember |
|||
Weighted Average Remaining Life (in years) | 2 years 2 months 14 days | |||
Weighted Average Exercise Price [Abstract] | ||||
Number of warrants |
721,897ent_ShareBasedCompensationSharesAuthorizedUnderEquityInstrumentsOtherThanOptionsExercisePriceRangeNumberOutstanding / us-gaap_ClassOfWarrantOrRightAxis = ent_CommonStockWarrantsMember / us-gaap_PlanNameAxis = ent_Row44WarrantsMember |
721,897ent_ShareBasedCompensationSharesAuthorizedUnderEquityInstrumentsOtherThanOptionsExercisePriceRangeNumberOutstanding / us-gaap_ClassOfWarrantOrRightAxis = ent_CommonStockWarrantsMember / us-gaap_PlanNameAxis = ent_Row44WarrantsMember |
||
Row 44 Warrants | Series C-2 Warrants | ||||
Share-based Compensation, Shares Authorized under Equity Instruments Other Than Options, Exercise Price Range [Line Items] | ||||
Exercise Price Per Warrant (as converted) |
$ 8.74ent_SharebasedCompensationSharesAuthorizedunderEquityInstrumentsOtherThanOptionsExercisePricePerWarrantasConverted / us-gaap_ClassOfWarrantOrRightAxis = ent_SeriesC2WarrantsMember / us-gaap_PlanNameAxis = ent_Row44WarrantsMember |
|||
Number of Warrants (in thousands) |
734,000ent_SharebasedCompensationSharesAuthorizedunderEquityInstrumentsOtherThanOptionsExercisePriceRangeNumberOutstandingasConverted / us-gaap_ClassOfWarrantOrRightAxis = ent_SeriesC2WarrantsMember / us-gaap_PlanNameAxis = ent_Row44WarrantsMember |
|||
Weighted Average Remaining Life (in years) | 2 years 5 months 4 days | |||
Global Eagle Warrants | ||||
Number of Warrants [Abstract] | ||||
Beginning Balance |
23,238us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
|||
Granted |
0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
|||
Exercised |
(3)ent_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriod / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
|||
Purchased |
(403)ent_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPurchasedinPeriod / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
|||
Exchanged for Global Eagle common stock |
(12,683)ent_ClassofWarrantorRightWarrantsExchanged / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
|||
Forfeited |
0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
|||
Ending Balance |
10,149us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
23,238us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
10,149us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
|
Weighted Average Exercise Price [Abstract] | ||||
Beginning Balance (in dollars per share) |
$ 11.50us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
|||
Granted (in dollars per share) |
$ 0.00us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
|||
Exercised (in dollar per share) |
$ 11.50ent_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFairValue / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
|||
Purchased (in dollar per share) |
$ 11.50ent_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPurchasesinPeriodWeightedAverageGrantDateFairValue / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
|||
Exchanged (in dollar per share) |
$ 11.50ent_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsExchangedinPeriodWeightedAverageGrantDateFairValue / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
|||
Forfeited (in dollars per share) |
$ 0.00us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
|||
Ending Balance (in dollars per share) |
$ 11.50us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
$ 11.50us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
$ 11.50us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
|
Outstanding, Weighted Average Remaining Contractual Term (in years) | 3 years 1 month 1 day | |||
Global Eagle Warrants | Public Warrants | ||||
Share-based Compensation, Shares Authorized under Equity Instruments Other Than Options, Exercise Price Range [Line Items] | ||||
Weighted Average Remaining Life (in years) | 3 years 1 month 2 days | |||
Weighted Average Exercise Price [Abstract] | ||||
Exercise price per warrant |
$ 11.50ent_ShareBasedCompensationSharesAuthorizedUnderEquityInstrumentsOtherThanOptionsExercisePricePerWarrant / us-gaap_ClassOfWarrantOrRightAxis = ent_PublicWarrantsMember / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
|||
Number of warrants |
10,149ent_ShareBasedCompensationSharesAuthorizedUnderEquityInstrumentsOtherThanOptionsExercisePriceRangeNumberOutstanding / us-gaap_ClassOfWarrantOrRightAxis = ent_PublicWarrantsMember / us-gaap_PlanNameAxis = ent_GlobalEagleWarrantsMember |
X | ||||||||||
- Definition
Class of Warrant or Right, Warrants Exchanged No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exchanged in Period, Weighted Average Grant Date Fair Value No definition available.
|
X | ||||||||||
- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other Than Options, Exercisable, Number No definition available.
|
X | ||||||||||
- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercises in Period No definition available.
|
X | ||||||||||
- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercises in Period, Weighted Average Grant Date Fair Value No definition available.
|
X | ||||||||||
- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Purchased in Period No definition available.
|
X | ||||||||||
- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Purchases in Period, Weighted Average Grant Date Fair Value No definition available.
|
X | ||||||||||
- Definition
Share-based Compensation, Shares Authorized under Equity Instruments Other Than Options, Exercise Price Per Warrant No definition available.
|
X | ||||||||||
- Definition
Share-based Compensation, Shares Authorized under Equity Instruments Other Than Options, Exercise Price Per Warrant as Converted No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Share-based Compensation, Shares Authorized under Equity Instruments Other Than Options, Exercise Price Range, Number Outstanding No definition available.
|
X | ||||||||||
- Definition
Share-based Compensation, Shares Authorized under Equity Instruments Other Than Options, Exercise Price Range, Number Outstanding as Converted No definition available.
|
X | ||||||||||
- Definition
Share-based Compensation, Shares Authorized under Equity Instruments Other Than Options, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|